Riskpilot← Back to searchSign inGet full accessAXCELLERA HOLDING AS
ASActiveOrg 989210785Ruglandveien 11, 1358 JarWholesale of pharmaceutical and medical goods · NACE 4646Est. 20060 employees
Revenue 2024
NOK 186K
-83% vs 2023
EBITDA margin
-119.8%
-140% vs 2023
Equity ratio
55.9%
Financial strength
Net profit 2024
NOK 815K
+49% vs 2023
| Revenue | NOK 186K | -83% |
| EBITDA | NOK -223K | -140% |
| Net profit | NOK 815K | +49% |
| Total assets | NOK 3,4M | +46% |
| Equity | NOK 1,9M | -10% |
| Employees | 0 | — |
Legal name
AXCELLERA HOLDING AS
Org number
989210785
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. januar 2006
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Konsulentvirksomhet innenfor innovasjon og ledelsesopplæring, deltakelse og investering i andre selskaper samt tjenester innen strategi, innovasjon og ledelse.
Address
Ruglandveien 11, 1358 Jar
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 736 | 2 390 | 1 077 | 1 094 | 186 |
| Staff expenses | −7 | −0 | −0 | −0 | −0 |
| EBITDA | 1 516 | 2 083 | 683 | 551 | −223 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 516 | 2 083 | 683 | 551 | −223 |
| Net financials | 1 365 | 93 | 22 | −4 | 1 038 |
| Profit before tax | 2 881 | 2 176 | 705 | 547 | 815 |
| Tax | −0 | 202 | 1 | 1 | −0 |
| Net profit | 2 881 | 1 975 | 704 | 546 | 815 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 106 | 3 563 | 2 725 | 2 301 | 3 351 |
| Equity | 1 429 | 2 364 | 2 083 | 2 083 | 1 873 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 677 | 1 199 | 642 | 218 | 1 478 |
| Total debt | 677 | 1 199 | 642 | 218 | 1 478 |
EBITDA margin
-119.8%
This company
15.8%
Market median
-858% vs market
20202024
Equity ratio
55.9%
This company
38.2%
Market median
+46% vs market
20202024
Return on equity
43.5%
This company
18.4%
Market median
+136% vs market
20202024
Net profit margin
438.6%
This company
8.1%
Market median
+5315% vs market
20202024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20202024
Debt / equity
0.79×
This company
0.62×
Market median
+27% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AW Deputy Member | Deputy Member | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2010 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AXCELLERA HOLDING AS (this company)
INNEOX ASBoard members of AXCELLERA HOLDING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anja Wikborg | Deputy Member | 0 companies |
| Yngve Kristiansen | Chairman | 0 companies |